158 related articles for article (PubMed ID: 17419183)
1. (1 --> 3)-beta-D-glucan--a new marker for the early serodiagnosis of deep-seated fungal infections in humans.
Kedzierska A
Pol J Microbiol; 2007; 56(1):3-9. PubMed ID: 17419183
[TBL] [Abstract][Full Text] [Related]
2. Invasive fungal infections: biomarkers and molecular approaches to diagnosis.
Schuetz AN
Clin Lab Med; 2013 Sep; 33(3):505-25. PubMed ID: 23931836
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of biological markers in the diagnosis of invasive candidiasis].
Pontón J
Rev Iberoam Micol; 2009 Mar; 26(1):8-14. PubMed ID: 19463272
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
[TBL] [Abstract][Full Text] [Related]
5. Comparable Serum and Plasma 1,3-β-d-Glucan Values Obtained Using the Wako β-Glucan Test in Patients with Probable or Proven Fungal Diseases.
De Carolis E; Marchionni F; Torelli R; Posteraro P; De Pascale G; Carelli S; Sanguinetti M; Posteraro B
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842228
[No Abstract] [Full Text] [Related]
6. Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis.
Marty FM; Koo S
Med Mycol; 2009; 47 Suppl 1():S233-40. PubMed ID: 18720216
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the clinical cutoff level of serum (1 --> 3)-beta-D-glucan in patients with connective tissue diseases complicated by deep fungal infections.
Kato K; Onoda S; Asano J; Fukaya S; Yoshida S
Mod Rheumatol; 2010 Aug; 20(4):366-9. PubMed ID: 20349101
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
Pickering JW; Sant HW; Bowles CA; Roberts WL; Woods GL
J Clin Microbiol; 2005 Dec; 43(12):5957-62. PubMed ID: 16333082
[TBL] [Abstract][Full Text] [Related]
9. Serodiagnosis of candidiasis, aspergillosis, and cryptococcosis.
de Repentigny L
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S11-22. PubMed ID: 1562681
[TBL] [Abstract][Full Text] [Related]
10. [Recent advances of serodiagnosis for systemic fungal infections].
Yoshida K
Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):135-42. PubMed ID: 16940946
[TBL] [Abstract][Full Text] [Related]
11. [1,3-Beta-D-glucan measurement and its usefulness in the diagnosis of invasive fungal infections].
Kocmanová I; Rácil Z; Koukalová D; Mayer J
Klin Mikrobiol Infekc Lek; 2008 Jun; 14(3):88-92. PubMed ID: 18688768
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic tests: Beta-D-glucan].
Mori T; Sugi Y
Nihon Rinsho; 2005 Jul; 63 Suppl 7():244-6. PubMed ID: 16111238
[No Abstract] [Full Text] [Related]
13. Beta-glucan in the diagnosis of invasive fungal disease.
Pasqualotto AC; Sukiennik TC
Clin Infect Dis; 2008 Jul; 47(2):292-3; author reply 293-4. PubMed ID: 18564936
[No Abstract] [Full Text] [Related]
14. Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?
Wingard JR
Best Pract Res Clin Haematol; 2012 Dec; 25(4):487-91. PubMed ID: 23200547
[TBL] [Abstract][Full Text] [Related]
15. Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.
McCarthy MW; Petraitiene R; Walsh TJ
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538702
[TBL] [Abstract][Full Text] [Related]
16. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of plasma (1-->3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections.
Mori T; Ikemoto H; Matsumura M; Yoshida M; Inada K; Endo S; Ito A; Watanabe S; Yamaguchi H; Mitsuya M; Kodama M; Tani T; Yokota T; Kobayashi T; Kambayashi J; Nakamura T; Masaoka T; Teshima H; Yoshinaga T; Kohno S; Hara K; Miyazaki S
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):553-60. PubMed ID: 9263735
[TBL] [Abstract][Full Text] [Related]
18. Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.
Presterl E; Parschalk B; Bauer E; Lassnigg A; Hajdu S; Graninger W
Int J Infect Dis; 2009 Nov; 13(6):707-12. PubMed ID: 19157947
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of fungal infection: new technologies for the mycology laboratory.
Alexander BD
Transpl Infect Dis; 2002; 4 Suppl 3():32-7. PubMed ID: 12486790
[TBL] [Abstract][Full Text] [Related]
20. [Problems and recent advances in measurement of (1-->3)-beta-D-glucan].
Yoshida K; Shoji H; Niki Y
Nihon Ishinkin Gakkai Zasshi; 2008; 49(2):75-80. PubMed ID: 18451587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
